Why the study?
Does intravenous ibutilide safely and successfully cardiovert atrial fibrillation in pregnant women?
Does intravenous ibutilide safely and successfully cardiovert atrial fibrillation in pregnant women?
Intravenous ibutilide may be a safe and effective option for the cardioversion of atrial fibrillation during pregnancy.
Answers are grounded in this paper and cite their sources.
May support ibutilide for AF cardioversion in pregnancy; hypothesis-generating and requires prospective validation.
We present two cases of successful cardioversion of atrial fibrillation using intravenous ibutilide during pregnancy. One patient had atrial fibrillation, complicating the Wolff-Parkinson-White syndrome and the other had a history of nonobstructive hypertrophic cardiomyopathy. No adverse maternal or fetal effects were observed during or after pregnancy in either case.
No takes yet. Share an insight, caveat, or question.
Kočková et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: